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Abstract
Magainin peptides, isolated from Xenopus skin, have broad spectra of antimicrobial activity and low toxicities to normal
eukaryotic cells, thus being good candidates for therapeutic agents. The mechanism of action is considered to be the
permeabilization of bacterial membranes. A number of studies using lipid vesicles have elucidated its molecular detail.
However, their interactions with bacteria are not yet well understood. In this paper, we synthesized several magainin
 .analogs with different charges 0 to q6 and hydrophobicities, and systematically studied their interactions with the outer
and inner membranes of three species of Gram-negative bacteria Escherichia coli, Acinetobacter calcoaceticus, Proteus
.  .˝ulgaris . The treatment of the E. coli cells with native magainin 2 q4 immediately induced the efflux of the intracellular
Kq ions and the cell death. A number of blebs were formed on the bacterial surface and the outer membrane became leaky.
An increase in the peptide’s positive charge enhanced the outer membrane permeabilization and the bactericidal activity.
The cationic peptides also effectively permeabilized the inner membranes rich in acidic phospholipids, indicating the
importance of electrostatic interactions. Substitution of Trp for Phe simultaneously increased the bactericidal activity and
the hemolytic activity. A strategy to develop potent antimicrobial peptides was discussed on the basis of these results.
q 1997 Elsevier Science B.V.
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1. Introduction
The widespread use of exogenous antibiotics in-
creases the resistance of pathogenic microorganisms
to them, posing a threat to their medical use in the
future. For the last decade, new classes of endoge-
nous peptidic antibiotics of animal origin have been
extensively investigated as alternatives for review
w x. w xsee 1,2 , e.g., cecropins from insects 3 , tachy-
w xplesins from horseshoe crab hemolymph 4 , magain-
w xins from frog skin 5 , and defensins from mam-
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w xmalian neutrophils 6 . These peptides possess the
common features of net positive charges due to the
presence of multiple Arg and Lys residues and of
forming amphipathic structures. Despite very diverse
peptide sequences and structures, the action mecha-
nisms of most host defense peptides are considered to
enhance the permeability of bacterial membranes
w x1,7–9 . A number of studies by use of lipid bilayers
as a model membrane system have been accumulated
to elucidate the molecular mechanisms of the mem-
brane permeabilization. However, the interactions of
these peptides with bacterial membranes have been
less extensively investigated.
Magainin peptides are isolated from the skin of the
African frog, Xenopus lae˝is, and possess antibiotic
activities against various microorganisms, including
Gram-positive and Gram-negative bacteria, fungi, and
w xprotozoa and even cancer cells 5,10,11 . It is gener-
ally accepted that membrane lipids constitute the
 .main target of the peptides, because 1 magainins
w xpermeabilize lipid bilayers 12–14 and form ion
w x  .channels 15,16 , and 2 all-D enantiomer peptides
are equipotent relative to the parent all-L peptides; the
action mechanism does not involve interactions with
w xa chiral receptor nor enzyme 17,18 . We have eluci-
dated the molecular mechanisms of the magainin-in-
wduced membrane permeabilization as follows 12–
x14,19–21 . Positively charged magainins preferen-
tially interact with acidic phospholipids to form am-
phiphilic helices, which lie parallel to the membrane
surface. Five helices spontaneously form membrane-
spanning pores of short duration. Upon the disintegra-
tion of the pores, a fraction of the peptides translo-
cates into the inner leaflets, causing pore deactiva-
tion. The pore lining is composed of not only the
hydrophilic residues of the peptides but also the lipid
head groups, allowing the rapid flip-flop of the lipids
by lateral diffusion through the pores. Thus, the
peptides can simultaneously dissipate the membrane
potential and the lipid asymmetry.
Magainins are expected to be good candidates for
therapeutic agents because they are preferentially ac-
tive toward prokaryotic membranes. Three factors
w x  .regulate this membrane selectivity 20 . 1 The outer
leaflets of normal eukaryotic cell membranes are
predominantly composed of zwitterionic lipids such
w xas phosphatidylcholine and sphingomyelin 22 , with
which the interactions of magainins are rather weak.
On the other hand, bacterial membranes abundantly
contain negatively charged lipids such as phos-
phatidylglycerol, cardiolipin and lipopolysaccharides
 .LPS , which significantly enhance the membrane
 .binding of the peptides. 2 Eukaryotic cell mem-
branes are rich in cholesterol, while bacterial cell
membranes are devoid of it. Cholesterol inhibits mag-
ainin-induced lysis of both erythrocytes and lipo-
 .somes. 3 Bacterial cells have large, inside-negative
transmembrane potentials promoting magainins’ at-
tack.
The development of potential antibiotic peptides
requires the detailed knowledge of peptide–bacteria
interactions, which is extremely lacking. Magainins
disorder the outer membrane of Salmonella ty-
w xphimurium 23–25 and dissipate the membrane po-
tential of the inner membrane of outer membrane-
w xpermeabilized Escherichia coli 26 . Do they lyse
this membrane? Is there a correlation between the
acidic lipid contents of the membrane and the suscep-
tibility of the bacteria to magainins? How do electro-
static interactions play a role in the magainin–bacteria
interactions? To shed light on these problems, we
carried out a systematic study using a series of
magainin 2 analogs of different electric charges. The
peptides with higher positive charges were found to
effectively permeabilize both the outer and inner
membranes. The lysis of the latter membrane was
correlated with the acidic phospholipid content.
2. Materials and methods
2.1. Materials
Magainin 2, its analogs, and tachyplesin I were
synthesized by use of a Fmoc-based solid phase
method and purified by RP-HPLC and gel filtration,
w xas reported previously 13,27,28 . Highly purified
melittin was obtained from Boehringer Mannheim
 .Mannheim, Germany . The absence of phospholipid
hydrolysis due to possible contamination of phospho-
lipase A was confirmed by a TLCrFID analyzer2
 .Iatroscan MK-5 Iatron Laboratories, Tokyo, Japan .
The purity and the concentration of the peptides were
determined by quantitative amino acid analysis. The
concentration of the Trp-containing peptides was rou-
tinely determined by the optical density at 280 nm.
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Lysozyme from chicken egg white was purchased
 .from Wako Tokyo, Japan . All other chemicals from
Wako were of special grade.
2.2. Bacteria
The bacterial strains used were Escherichia coli
 . ATCC 8739 , Acinetobacter calcoaceticus ATCC
.  .14987 , and Proteus ˝ulgaris ATCC 13315 from
 .the Institute for Fermentation Osaka, Japan . The
 . bacteria were grown at 378C in a medium grl 10
 ..casein peptoner5 yeast extractr10 NaCl pH 7.0 .
The cells were harvested in the mid-logarithmic
growth phase and washed three times with a Hepes
  ..buffer 10 mM Hepesr150 mM NaCl pH 7.0 .
2.3. Antimicrobial acti˝ities
The peptides were sterilized through a 0.22 mm
filter and stepwise-diluted. The bacterial cells were
mixed with each peptide and the medium in a 96-well
w xtissue culture plate 28 . The final composition of the
bacterial suspension was 10 mM Hepesr150 mM
 .  .NaClr1% wrv casein peptoner0.5% wrv yeast
6 extractrpeptider10 CFUrml bacterial cells pH
.7.0 . Microbial growth was determined by the in-
crease in optical density at 405 nm, after an 8 h
incubation at 378C. The minimum inhibitory concen-
 .tration MIC was defined as the lowest concentration
of the peptides at which there was no change in
optical density between time 0 and 8 h. The z-poten-
tial of the bacteria was calculated by use of Smolu-
w xchowski’s equation 29 from their electrophoretic
mobilities in the Hepes buffer at 258C measured on
an electrophoretic light scattering spectrophotometer
 .Zetasizer 4; Malvern Instruments .
2.4. K q efflux from E. coli cells
E. coli cells were grown to the mid-logarithmic
growth phase, washed three times with the Hepes
buffer and then resuspended in the same buffer at
5P108 CFUrml. The Kq efflux from the cells after
addition of magainin 2 was monitored by a Kq
ion-selective electrode connected to a microprocessor
ion analyzer model 901 Orion Research, Boston,
. w xUSA 30 .
2.5. Measurement of cell ˝iability
The cell viability was measured under the same
conditions as the Kq permeability measurements.
 .Samples 10 ml collected at intervals were immedi-
ately diluted 100-fold to stop the antimicrobial activ-
ity of the peptide, and 100 ml of the diluted sample
was dispersed onto five petri dishes with an agar
 . medium grl 15 agarr10 casein peptoner5 yeast
.extractr10 NaCl . The cell viability was determined
by counting colonies after a 20 h incubation at 378C.
2.6. Outer membrane permeability
Bacterial cells in the mid-logarithmic phase were
suspended at a density of 1P107 CFUrml in the
Hepes buffer and preincubated with the peptides at
378C for 10 min. A nonionic surfactant, HED, was
 .then added to a final concentration of 0.005% wrv ,
and the incubation was continued. The change in
turbidity was monitored by measuring the optical
density at 400 nm.
2.7. Scanning electron microscopy
E. coli cells were incubated with magainin 2 at
378C for 30 min in the Hepes buffer. The cells were
then chemically fixed with 2.5% glutaraldehyde for 2
 .h, collected on a Nuclepore filter pore size, 0.2 mm
by filtration, and washed three times with the buffer.
The cells on the filter were fixed with 1% osmic acid
for 1 h and subsequently dehydrated with a graded
ethanol series. The samples were lyophilized, coated
with gold in an ion coater, and examined by scanning
electron microscopy on an Hitachi S450 instrument.
2.8. Spheroplast lysis
Spheroplasts of Gram-negative bacteria were pre-
pared by treating stationary phase cells with
w xlysozyme-EDTA 31 and washed three times with a
Hepes buffer 10 mM Hepesr150 mM NaClr250
 ..mM sucrose pH 7.0 . The spheroplasts were added
to the peptide, and the optical density at 500 nm was
monitored at 378C for 10 min. The lysis of the
spheroplasts was measured as a decrease in optical
density. For the maximal lysis, the suspension was
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sonicated twice for 5 min in an ice bath. Lipids were
extracted from each spheroplast suspension by the
w xBligh–Dyer method 32 . The individual phospho-
lipids were quantitated by the TLCrFID analyzer.
2.9. Hemolytic assays
The hemolytic activities of the peptides were de-
termined by use of fresh human erythrocytes blood
.type A . The blood was centrifuged and washed three
times with a Hepes buffer 10 mM Hepesr150 mM
 ..NaClr1 mM EDTA pH 7.4 to remove the plasma
and buffy coat. Peptide solutions were incubated with
an erythrocyte suspension final erythrocyte concen-
.tration, 1% vrv at 378C for 1 h. The percent hemol-
ysis was determined from the optical density at 540
nm of the supernatant after centrifugation 800=g,
. w x10 min , as described elsewhere 33 . Hypotonically




In the present study, we have assessed four analog
 .peptides of magainin 2 MG2 to investigate the
 .effect of charge on the bactericidal activity Fig. 1 .
The strategy of the chemical modification was de-
w xscribed in detail elsewhere 34 . The parent MG2
possesses a net charge of q4 under physiological
conditions. We assume that the a-NH and His2
groups are protonated, because magainins preferen-
tially interact with negatively charged membranes,
.the local pH of whose surface is slightly acidic. To
reduce the positive charge, we synthesized two
analogs in which negatively charged Glu residues
 .Fig. 1. Amino acid sequences of magainin 2 MG2 and its
analogs.
were substituted for Lys residues at the 10th andror
11th positions 10E,12W-MG2 and 10E,11E,12W-
.MG2 . In these analogs, a Trp residue was introduced
w xat the 12th position 28 . A 19Q-MG2a analog with
an increased net charge had a Gln residue for Glu at
the 19th position and the amidated C-terminus.
3.2. Antimicrobial assay
The antimicrobial activities of MG2, its four
analogs, tachyplesin I, and melittin were assayed
 .against Gram-negative bacteria Table 1 . All pep-
tides, except inactive 10E,11E,12W-MG2, exhibited
similar antibacterial spectra: A. calcoaceticus and E.
coli were rather susceptible to these agents, whereas
P. ˝ulgaris was relatively resistant. No correlation
was found between the susceptibility and the z-poten-
tial of the bacterial surface.
The rank order of antimicrobial activity of the
 .  .peptide was tachyplesin I q7 )melittin q6 )
 .  .  .19Q-MG2a q6 G12W-MG2 q4 )MG2 q4
 .  .)10E,12W-MG2 q2 )10E,11E,12W-MG2 "0 .
The antimicrobial activity tends to increase with the
net positive charge.
3.3. Hemolytic acti˝ities
As a measure of toxicity, the hemolysis of human
erythrocytes induced by the magainin analogs was
Table 1
Antimicrobial activity of membrane-active peptides and z-potential of bacteria
 .Bacteria z-potential MIC mM
 .mV tachyplesin I melittin 19Q-MG2a MG2 12W-MG2 10E,12W-MG2 10E,11E,12W-MG2
a .  .  .  .  .  .  .q7 q6 q6 q4 q4 q2 "0
A. calcoaceticus y8.9 0.781 3.13 6.25 25 6.25 50 )100
E. coli y12.9 0.781 )12.5 6.25 50 12.5 100 )100
P. ˝ulgaris y14.9 3.13 )12.5 )100 )200 )200 )200 )100
a The net charge of each peptide at physiological conditions is shown in parentheses.
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Fig. 2. Hemolytic activity of MG2 and its analogs. Each peptide
solution at various concentrations was incubated with human
 .erythrocyte suspension final erythrocyte concentration, 1% vrv
at 378C for 1 h. The percent hemolysis value was colorimetrically
determined. Peptides: ’, 19Q-MG2a; v, MG2; ‘, 12W-MG2;
\, 10E,12W-MG2; I, 10E,11E,12W-MG2. The error bars rep-
resent the standard deviation of triplicate samples. The
10E,11E,12W-MG2 peptide was insoluble at concentrations
greater than 250 mM.
 .measured Fig. 2 . The hemolytic activity of 19Q-
 .MG2a closed triangles was approximately equiva-
 .lent to the potency of MG2 closed circles . The
Glu-substituted magainin 2 analogs open triangles
.and open squares showed weaker hemolytic activi-
ties. The introduction of Trp enhanced the toxicity
 .cf. open and closed circles .
3.4. K q efflux from E. coli cells
To gain an insight into the relationship between
the inner membrane permeabilization and cell death,
we simultaneously measured the efflux of intra-
cellular potassium ions and the cell viability by a
Kq-selective electrode and an agar plate method,
respectively. Fig. 3 shows that the addition of maga-
inin 2 to E. coli cells induced a Kq efflux from the
 . cells solid lines and a reduced cell viability closed
.circles . The percent cell viability value rapidly de-
creased to reach a plateau value of ca. 50% within 5
min at a peptide-to-cell ratio of 0.1 nmolr106 CFU
 . qFig. 3A . The K efflux also started immediately
after the addition of the peptide. The ion leakage
leveled off at about 20 min. Even at a lower peptide-
to-cell ratio of 0.01 nmolr106 CFU, a short contact
of the peptide with the bacteria caused the Kq ion
 .leakage and the cell death Fig. 3B . The presence of
10 mM Mg2q, however, prevented both the Kq
efflux and the cell viability loss open circles and
.dotted line in Fig. 3A .
3.5. Outer membrane permeability
The peptide-induced permeabilization of E. coli
outer membranes was examined on the basis of resis-
tance of the bacteria to a low concentration of a
surfactant. We used a nonionic surfactant HED in-
w xstead of SDS 35 to avoid a complicated interpreta-
tion of data due to the involvement of electrostatic
interactions. Fig. 4 depicts that the preincubation of
the E. coli cells with the peptide for 10 min rendered
the cells susceptible to 0.005% wrv HED. They were
rapidly lysed upon the addition of the surfactant
 .dashed line , whereas in the absence of the peptide,
the detergent addition hardly reduced the turbidity
 .solid line . This result suggests that the peptide
disrupts the barrier function of the outer membrane of
the Gram-negative bacteria to allow the surfactant to
permeate, leading to bacterial lysis. The DO.D. value
10 min after the HED treatment shown in the figure
q  .  .Fig. 3. Time course of the amount of K efflux solid lines from E. coli cells and the cell viability solid circles after the addition of
MG2. The data in the presence of 10 mM MgCl are shown by dotted lines and open circles. MG2 was added to an E. coli cell2
 8 .  6 .suspension 5P10 CFUrml at time 0. Peptide-to-cell ratio nmolr10 CFU : panel A, 0.1; panel B, 0.01.
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Fig. 4. Time course of outer membrane permeabilization. An E.
 7 . coli cell suspension 1P10 CFUrml preincubated with dashed
.  .  6line or without solid line 12W-MG2 0.5 mM, 0.05 nmolr10
. CFU at 378C for 10 min. HED final concentration, 0.005%
.wrv was then added at time 0, and the incubation was contin-
 .ued. The change in turbidity DO.D. was monitored by the
optical density at 400 nm.
can be used as a measure of the outer membrane
lesion caused by the peptide.
We examined the effect of the peptide charge on
the peptide-induced permeabilization of the outer
 .membranes of the E. coli cells Fig. 5A . The percent
change in the O.D. value during 10-min incubation
was plotted as a function of the amount of the added
peptide per cell. The rank order of the damage to the
 .outer membrane was 19Q-MG2a q6 )12W-MG2
 .  .  .q4 f MG2 q4 ) 10E,12W-MG2 q2 )
 .10E,11E,12W-MG2 "0 , again in accordance with
the decreasing order of the positive charges. The
potency was roughly reduced by an order of magni-
tude for every loss of 2 positive charges.
Fig. 5B compares the outer membrane disruption
activities of 12W-MG2 against the three Gram-nega-
tive bacteria. The outer membranes of P. ˝ulgaris
 .circles appeared to be significantly less susceptible
 .to the peptide than those of E. coli triangles and A.
 .calcoaceticus squares . This observation can at least
partially explain the difference in the antimicrobial
 .activities Table 1 .
3.6. Scanning electron microscopy
In order to gain a more direct insight into the
interaction of MG2 with E. coli , we examined the
bacteria treated with the peptide by scanning electron
 .microscopy. The untreated E. coli cells Fig. 6A had
a smooth surface. In contrast, as shown in Fig. 6B,
the E. coli cells showed clear morphological changes
under the conditions where the bacterial viability had
decreased by about 30% at the peptide-to-cell ratio of
6  .0.01 nmolr10 CFU Fig. 3B . The changes caused
by MG2 appeared to involve the formation of blebs
on the cell surface. Furthermore, string-like sub-
stances, which are considered to be cellular debris
arising from cell lysis, were seen around the cells
when the concentration of MG2 was increased to 0.1
6  .nmolr10 CFU Fig. 6C .
3.7. Inner membrane permeability
The peptide-induced permeabilization of bacterial
cytoplasmic membranes was measured on the basis
 .of the lysis a decrease in O.D. 500 of the sphero-
plasts of the Gram-negative bacteria. The kinetics of
lysis was very rapid without a measurable time lag
Fig. 5. Dependence of outer membrane permeability on peptide
charge and bacterial species at 378C. The percent charge in O.D.
400 10 min after the addition of HED was determined as shown
 .in Fig. 4. A E. coli cells were incubated with various peptides.
’, 19Q-MG2a; v, MG2; ‘, 12W-MG2; \, 10E,12W-MG2;
 .I, 10E,11E,12W-MG2. B 12W-MG2 was applied to various
bacterial species. ’, E. coli; B, A. calcoaceticus; v, P.
˝ulgaris. The error bars represent the standard deviation of three
experiments.
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 .Fig. 7 . Fig. 8A shows the dose response curves of
the lysis of the E. coli spheroplasts induced by the
magainin 2 analogs. The concentration of the cells
was expressed as that of the extracted membrane
lipids. At a peptide-to-lipid molar ratio of 0.25, 12W-
 .MG2 q4 lysed 50% of the cells during 10 min
 .open circles . The lysis triggered by 10E,12W-MG2
 .q2, open triangles was one order of magnitude
 .weaker than that by 12W-MG2 q4 . Neutral
10E,11E,12W-MG2 was additionally less potent
 .open squares . In contrast to the outer membrane
permeabilization, the lytic activity of 19Q-MG2a
 .q6, closed triangles was similar to those of MG2
 .  .q4, closed circles and 12W-MG2 q4 .
Fig. 7. Time course of E. coli spheroplast lysis. E. coli sphero-
plasts were incubated with 12W-MG2 at 378C for 10 min. The
change in turbidity was monitored by the optical density at 500
 .nm. Peptide concentration mM : trace 1, 0; trace 2, 2; trace 3, 4;
trace 4, 6.
Fig. 6. Scanning electron microscopy of E. coli treated with MG2. E. coli cells were incubated with MG2 at 378C for 30 min and the
 .  .  6specimens were then prepared for scanning electron microscopy. A Intact bacteria; B bacteria treated with MG2 0.01 nmolr10
.  .  6 .CFU ; C bacteria treated with MG2 0.1 nmolr10 CFU . The bars represent 0.5 mm.
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Fig. 8. Dependence of inner membrane permeability on peptide
charge and bacterial species at 378C. The percent change in O.D.
500 10 min after the addition of each peptide was determined as
 .depicted in Fig. 7. A E. coli spheroplast were incubated with
various peptides. ’, 19Q-MG2a; v, MG2; ‘, 12W-MG2; \,
 .10E,12W-MG2; I, 10E,11E,12W-MG2. B 12W-MG2 was
added to various spheroplasts. ’, E. coli; B, A. calcoaceticus;
v, P. ˝ulgaris. The error bars represent the standard deviation of
three experiments.
Fig. 8B illustrates the sensitivity of the sphero-
plasts of the three bacteria to 12W-MG2-induced
 .lysis. The spheroplasts of P. ˝ulgaris circles were
much less susceptible to the peptide than those of E.
 .  .coli triangles and A. calcoaceticus squares . Table
Table 2
Phospholipid composition of the spheroplasts of Gram-negative
bacteria a
Bacteria % of lipid
cardiolipin phosphatidyl- phosphatidyl-
glycerol ethanolamine
A. calcoaceticus 12.6"0.7 34.7"2.5 52.7"2.1
E. coli 8.2"0.7 23.9"0.9 67.9"1.1
P. ˝ulgaris 5.8"0.5 16.8"1.0 77.4"1.3
a Phospholipids were extracted from each spheroplast suspension
w xby the Bligh–Dyer method 32 . The individual phospholipids
 .were quantitated by the TLCrFID analyzer. Mean"S.D. ns5 .
2 summarizes the phospholipid compositions of the
three spheroplast membranes, which were found to be
composed of zwitterionic phosphatidylethanolamine,
anionic phosphatidylglycerol and cardiolipin. A good
correlation was found between the acidic phospho-
 .lipid content Table 2 and the peptide susceptibility
 .Fig. 8B .
4. Discussion
There is a consensus that the action mechanism of
this class of peptides is to disrupt the barrier proper-
ties of bacterial membranes. However, it is still con-
troversial because of the lack of basic knowledge if
their ultimate target is the outer membrane or the
inner membrane. Westerhoff and his coworkers
w x26,36 proposed that the cytoplasmic membrane,
containing the electron transport chain and the en-
zymes for oxidative phosphorylation, is the site of
w xaction. The group of Blazyk 23–25 pointed out the
importance of magainin-outer membrane interactions
in addition to the involvement of the inner mem-
brane. It was recently reported by use of magainin 2
covalently fixed to a resin that magainin’s actions on
the bacterial surface are sufficient for its lethal activ-
w xity 37 . We have systematically examined the inter-
actions of the magainin peptides with both outer and
inner membranes to map out a strategy for the devel-
opment of potent peptidic antibiotics.
4.1. Inner membrane
Magainin 2 and its analogs rapidly lysed the
spheroplasts of the Gram-negative bacteria without
 .any discernible lag Fig. 7 , indicating that the pep-
tides can directly permeabilize the cytoplasmic mem-
branes. Electrostatic interactions between the posi-
tively charged peptides and the negatively charged
lipids play important roles in this process: The lysis
of the inner membranes was correlated with the
 .acidic phospholipid content Fig. 8B, Table 2 . Fur-
thermore, the peptides with higher positive charges
  .  .  ..19Q-MG2a q6 , MG2 q4 , and 12W-MG2 q4
were more active than the less basic peptides
  .10E,12W-MG2 q2 and 10E,11E,12W-MG2
 .."0 . The observation that the most basic 19Q-
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MG2a is not more potent compared with the q4
peptides can be attributed to the fact that the 19Q-
MG2a pore formed in the membrane is rather unsta-
ble because of the closely spaced positive charges
w x34 .
4.2. Outer membrane
Magainins should cross the outer membranes to
reach the cytoplasmic membrane. To demonstrate the
alteration of the outer membrane permeability, we
 .used the amphiphilic agent, HED Fig. 4 . It pene-
trates the intact outer membrane only poorly, because
the membrane serves as a barrier to amphiphilic and
w xhydrophobic molecules 38 . The peptides disrupt the
barrier function of the outer membrane. Electrostatic
interactions also appear to be one of the factors
controlling the process. More positive peptides caused
 .stronger membrane disturbances Fig. 5A . In con-
trast to the inner membrane permeabilization, 19Q-
MG2a more effectively disrupts the outer membrane,
suggesting that the mode of action could be different
between the two membrane systems. The presence of
Mg2q ions protected E. coli cells from the
magainin-induced loss of the viability and the Kq
 w x.efflux Fig. 3A; 39 . Because divalent cations nor-
mally function as cationic bridges between adjacent
phosphates of LPS, cationic peptides were suggested
Fig. 9. Viability of MG2-treated E. coli cells. The E. coli cells
were incubated with MG2, as in Fig. 3A. After 2 and 20 min,
aliquots from the specimen were diluted 5P105-fold. The diluted
cells were plated onto petri dishes with the agar medium immedi-
 .  .ately empty bars or after another 1 h incubation filled bars .
The percent viability was determined by counting colonies after a
20 h incubation at 378C.
to compete with the cations, thus destroying the LPS
cross-bridging and disturbing the outer membrane
 w x.‘self-promoted pathway’; 40 , which accompanies
 .morphological changes in the E. coli surface Fig. 6 .
On the other hand, factors other than electrostatic
interactions should be taken into account to explain
the susceptibility differences among various bacterial
species. The outer membrane of P. ˝ulgaris is less
susceptible to 12W-MG2 than those of E. coli and
A. calcoaceticus in spite of its most negatively
 .charged surface Fig. 5B and Table 1 . Proteus
species are inherently very resistant to polymyxin
w x41 . The mechanism of polymyxin resistance in Pro-
teus mirabilis is related to the high content of phos-
w xphate-linked 4-aminoarabinose in its LPS 42 .
4.3. Bactericidal acti˝ity
Fig. 3 clearly shows that instantaneously after the
peptide treatment, both the cell viability decrease and
the Kq efflux were observed, suggesting that the
rapidly formed lesion in the inner membrane is closely
related to cell death. It should be noted here that the
cell viability was determined by the agar plate method
immediately after the dilution of the specimen. For a
microbial cell, death is defined as the irre˝ersible
 .loss of the ability to reproduce grow and divide .
The conditions of incubation in the first hour are
w xcritical in the determination of killing 43 . Therefore,
we confirmed that the death of the cells induced by
MG2 is irreversible. The E. coli cells were incubated
with MG2, as in Fig. 3. After 2 and 20 min, aliquots
from the specimen were diluted 5=105 fold, and the
diluted cells were further incubated for 1 h. The
colony-forming potency was then examined. Fig. 9
shows that the post-incubation failed to repair the
bacterial reproducing ability. Therefore, we conclude
that the initial contact of the cells with the peptide
triggers the membrane disruption, causing the bacte-
rial death. The leakage of a cytoplasmic enzyme,
 .b-galactosidase, was undetectable data not shown
implying that the size of the peptide-induced lesion is
not very large. Similar phenomena have been re-
ported for other peptides. Polymyxin did not release a
cytoplasmic enzyme, glucose-6-phosphate dehydro-
genase, from Salmonella typhimurium when a major-
w xity of the bacteria are killed 44 .
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4.4. De˝elopment of potent peptidic antibiotics
Antimicrobial peptides of therapeutic value should
simultaneously fulfill the two requirements, i.e., a
low toxicity and a high bactericidal activity. Both
factors are closely related to the peptide–membrane
interactions, which are largely affected by the affinity
of the peptide for the target membrane. The binding
energy originates from both the intrinsic chemical
affinity, mainly due to hydrophobic interactions, and
electrostatic contributions. The former dominates in
the peptide-induced hemolysis, because the erythro-
cyte surface is exclusively composed of zwitterionic
phospholipids, such as phosphatidylcholine and sph-
w xingomyelin 22 . Actually, we demonstrated that the
lytic activities of several peptides against phos-
phatidylcholine liposomes correlate with those against
w xhuman erythrocytes 20 . Furthermore, Blondelle and
w xHoughten 45 found a good correlation between the
hemolytic activities of the position-specific omission
analogs of melittin and their retention times on RP-
HPLC. The observation that the introduction of Trp
 .enhanced the sensitivity to the erythrocytes Fig. 2
may also be attributed to the enhanced hydrophobic-
ity, although Trp shows variability in assigned hy-
drophobicity among different scales. The hydropho-
w xbicity difference of ca. 0.6 kcalrmol 46 would
increase the binding affinity 3-fold. The presence of
the NH group in Trp capable of hydrogen-bonding
may also be related to the higher activity of the Trp
containing peptide. Another possibility would be the
bulkiness of the side chain compared to that of Phe
w x47 . The most basic magainin derivative, 19Q-MG2a,
possesses a hemolytic activity even slightly weaker
 .than that of MG2 Fig. 2 , probably because of the
w xshorter life span of the former peptide 34 , as in the
case of the inner membrane permeabilization. The
reason for the weak hemolytic potency of 10E,12W-
MG2 is not clear at present. One possibility would be
that the peptide with the less positive charge is easier
to self-aggregate in aqueous solution at high concen-
trations.
In the peptide–bacteria interactions, electrostatic
interactions become dominant because of the pres-
ence of LPS and acidic phospholipids. An increase in
peptide positive charge enhanced the outer membrane
 .disruption Fig. 5A , leading to the augmentation in
 .the antibacterial activity Table 1 . This strategy is
often used to improve the bactericidal activity of
w xpeptides 39,48 . The observations that a free amino
terminus is required to elicit the maximal antimicro-
w xbial activity 49 and that a decrease in pH from 7.2
to 6 enhances the bactericidal activity of magainin
w xanalogs 48 can be understood on the basis of the
enhanced basicity of the peptide. However, an in-
crease in the peptide positive charge does not always
augment the bactericidal activity, suggesting a com-
w xplex nature of the peptide–bacteria interactions 48 .
Hydrophobicity enhancement is also a method of
intensifying the antibiotic potency, as can be seen
from the comparison between MG2 and 12W-MG2
 .Table 1 . However, this type of modification simul-
 .taneously raises the toxicity vide supra . Chen et al.
w xreported 49 that Gly“Ala and Ser“Ala substitu-
tions greatly enhance the antimicrobial activity of
magainin, whereas in most cases the hemolytic activ-
ity is simultaneously raised. One of the derivatives,
magainin A, was suggested to have a higher mem-
w xbrane affinity than the parent peptide 50 , probably
because of its enhanced hydrophobicity.
The antibacterial spectra are regulated by the outer
membrane permeability and the acidic lipid content
of the cytoplasmic membrane: the insusceptibility of
P. ˝ulgaris to magainin can be understood on the
basis of the resistance of its outer membrane Fig.
.5B and the low acidic lipid content of the inner
 .membrane Fig. 8B and Table 2 . It seems to be
 .difficult to alter the antimicrobial spectrum Table 1 ,
w xas found for a set of magainin analogs 49 .
In summary, we systematically investigated the
interactions of a series of magainin analogs with
three Gram-negative bacteria. An amphiphilic peptide
of a high basicity and a low hydrophobicity would be
a promising candidate for a therapeutic agent, in
keeping with the results from a number of structure–
w xactivity relationship studies 51 . Other factors, such
as helicity and chain length, are of course should be
taken into consideration.
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